Pathophysiology of the hepoxilins

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 4, 2015, Pages 383-396

  Pace Asciak, Cecil R ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Hepoxilin; Inflammation; Pathophysiology

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ADENYLATE CYCLASE; ARACHIDONIC ACID; BLEOMYCIN; CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN; HEPOXILIN; HYDROLASE; ICOSANOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; 12-HPETE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; AUTACOID; DIHOMO GAMMA LINOLENIC ACID; LEUKOTRIENE;

ALLODYNIA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL INFECTION; BLOOD VESSEL PERMEABILITY; BRAIN; BRAIN FUNCTION; CALCIUM CELL LEVEL; CELL VOLUME; DIABETES MELLITUS; GENETIC DISORDER; HUMAN; HYPERALGESIA; HYPOPHYSIS; ICHTHYOSIS; INFLAMMATION; INSULIN RELEASE; LUNG; LUNG FIBROSIS; METABOLITE; NEOPLASM; NEUTROPHIL; NONHUMAN; PAIN; PANCREAS ISLET; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN; THROMBOCYTE AGGREGATION; THROMBOSIS; VASOCONSTRICTION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOTRIENES; MOLECULAR STRUCTURE; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84922513752     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.09.007     Document Type: Review

References (151)

1. C.R. Pace-Asciak, E. Granström, and B. Samuelsson Arachidonic acid epoxides: isolation and structure of 2 hydroxy epoxide intermediates in the formation of 8,11,12-trihydroxy eicosatrienoic acid and 10,11,12-trihydroxy eicosatrienoic acid J. Biol. Chem. 258 1983 6835 6840
2. C.R. Pace-Asciak Formation of hepoxilin A4, B4 and the corresponding trioxilins from 12(S)-hydroperoxy-5,8,10,14,17-icosapentaenoic acid Prostaglandins Leukot. Med. 22 1986 1 9
3. D. Reynaud, and C.R. Pace-Asciak Docosahexaenoic acid causes accumulation of free arachidonic acid in rat pineal gland and hippocampus to form hepoxilins from both substrates Biochim. Biophys. Acta Lipids Lipid Metab. 1346 3 1997 305 316
4. A. Muñoz-Garcia, C. Thomas, D. Keeney, Y. Zheng, and A. Brash The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1841 2014 401 408
5. C.R. Pace-Asciak Arachidonic acid epoxides. Demonstration through oxygen-18 labeled oxygen gas studies of an intramolecular transfer of the terminal hydroxyl group of 12S-hydroperoxy-eicosa-5,8,10,14-tetraenoic acid to form hydroxy epoxides J. Biol. Chem. 259 1984 8332 8337
6. C.R. Pace-Asciak, K. Mizuno, and S. Yamamoto The enzymatic conversion of arachidonic acid into 8,11,12-trihydroxyeicosatrienoic acid Biochim. Biophys. Acta 712 1982 142 145
7. D. Reynaud, P. Demin, and C.R. Pace-Asciak Hepoxilin A3 formation in the rat pineal gland selectively utilises 12(S)-HPETE but not 12(R)-HPETE J. Biol. Chem. 269 1994 23976 23980
8. C.R. Pace-Asciak, D. Reynaud, and P. Demin Mechanistic aspects of hepoxilin biosynthesis J. Lipid Mediat. Cell Signal. 12 2-3 1995 307 311
9. W. Boeglin, R. Kim, and A. Brash A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression Proc. Natl. Acad. Sci. U. S. A. 95 1998 6744 6749
10. S. Nigam, P. Shankarnarayanan, and R. Ciccoli The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity J. Biol. Chem. 279 2004 29023 29030
11. A.R. Brash, Z. Yu, W.E. Boeglin, and C. Schneider The hepoxilin connection in the epidermis FEBS J. 274 2007 3494 3502
12. P. Krieg, and G. Fürstenberger The role of lipoxygenases in epidermis Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1841 2014 390 400
13. C.R. Pace-Asciak, and W.-S. Lee Purification of hepoxilin epoxide hydrolase from rat liver J. Biol. Chem. 264 1989 9310 9313
14. A. Cronin, M. Decker, and M. Arand Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase J. Lipid Res. 52 2011 712 719
15. P.M. Demin, and C.R. Pace-Asciak Synthesis of racemic 11,12-cyclopropyl analogs of hepoxilins A3 and B3 Tetrahedron Lett. 34 1993 4305 4308
16. C. Pace-Asciak, X. Li, D. Reynaud, N. Qiao, P. Demin, and M. Abdelhaleem Alterations in eicosanoid levels during U937 bcl-xL tumour growth suppression and recovery in NU/NU mice in vivo - involvement of phospholipase A2 Prostaglandins Other Lipid Mediat. 107 2013 43 47
17. C.R. Pace-Asciak, K. Mizuno, and S. Yamamoto Resolution by DEAE cellulose chromatography of the enzymatic steps in the transformation of arachidonic acid into 8,11,12-trihydroxy eicosatrienoic acid and 10,11,12-trihydroxy eicosatrienoic acid by rat lung Prostaglandins 25 1983 79 84
18. C.R. Pace-Asciak, and J.M. Martin Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets Prostaglandins Leukot. Med. 16 1984 173 180
19. C.R. Pace-Asciak, J.M. Martin, and E.J. Corey Hepoxilins, potential endogenous mediators of insulin release Prog. Lipid Res. 25 1986 625 628
20. C.R. Pace-Asciak, J.M. Martin, E.J. Corey, and W.-G. Su Endogenous release of hepoxilin A3 from isolated perifused pancreatic islets of Langerhans Biochem. Biophys. Res. Commun. 128 1985 942 946
21. D. Reynaud, I. Delton, A. Gharib, N. Sarda, M. Lagarde, and C.R. Pace-Asciak Formation, metabolism, and action of hepoxilin A3 in the rat pineal gland J. Neurochem. 62 1994 126 133
22. C.R. Pace-Asciak, J.M. Martin, and S.-P. Lee Appearance of prostaglandins, thromboxane B2 and hepoxilin A3 in the circulation of the normal and diabetic (BB) rat after arachidonic acid administration - correlation with plasma insulin Biochem. Cell Biol. 66 1988 901 909
23. C.R. Pace-Asciak, S.P. Lee, and J.M. Martin In vivo formation of hepoxilin A3 in the rat Biochem. Biophys. Res. Commun. 147 1987 881 884
24. O. Laneuville, M. Chang, C.C. Reddy, E.J. Corey, and C.R. Pace-Asciak Isozyme specificity in the conversion of hepoxilin A3 (HxA3) into a glutathionyl hepoxilin (HxA3-C) by the Yb2 subunit of rat liver glutathione S-transferase J. Biol. Chem. 265 1990 21415 21418
25. O. Laneuville, E.J. Corey, R. Couture, and C.R. Pace-Asciak Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate Biochim. Biophys. Acta 1084 1991 60 68
26. C.R. Pace-Asciak, O. Laneuville, M. Chang, C.C. Reddy, W.-G. Su, and E.J. Corey New products in the hepoxilin pathway: isolation of 11-glutathionyl hepoxilin A3 through reaction of hepoxilin A3 with glutathione S-transferase Biochem. Biophys. Res. Commun. 163 1989 1230 1234
27. C.R. Pace-Asciak, O. Laneuville, and W.-G. Su A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system Proc. Natl. Acad. Sci. U. S. A. 87 1990 3037 3041
28. A. Margalit, Y. Sofer, S. Grossman, D. Reynaud, C.R. Pace-Asciak, and A. Livne Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets Proc. Natl. Acad. Sci. U. S. A. 90 1993 2589 2592
29. M.M. Wang, D. Reynaud, and C.R. Pace-Asciak In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability Biochim. Biophys. Acta Lipids Lipid Metab. 1436 3 1999 354 362
30. P. Shankaranarayanan, R. Ciccoli, and S. Nigam Biosynthesis of hepoxilins: evidence for the presence of a hepoxilin synthase activity in rat insulinoma cells FEBS Lett. 538 2003 107 112
31. M. Sutherland, P. Shankaranarayanan, T. Schewe, and S. Nigam Evidence for the presence of phospholipid hydroperoxide glutathione peroxidase in human platelets: implications for its involvement in the regulatory network of the 12-lipoxygenase pathway of arachidonic acid metabolism Biochem. J. 353 2001 91 100
32. S. Nigam, and M.-P. Zafiriou Hepoxilin A3 synthase - a review Biochem. Biophys. Res. Commun. 338 2005 161 168
33. S. Pattabhiraman Transcriptional regulation of 12/15-lipoxygenase expression and the implication of the enzyme in hepoxilin biosynthesis and apoptosis http://edoc.hu-berlin.de/dissertationen/pattabhiraman-shankaranarayanan-2003-11-03/HTML/chapter1.html 2004
34. F. Jobard, C. Lefèvre, and A. Karaduman Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1 Hum. Mol. Genet. 11 2002 107 113
35. C. Lefèvre, B. Bouadjar, and A. Karaduman Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis Hum. Mol. Genet. 13 2004 2473 2482
36. Z. Yu, C. Schneider, W.E. Boeglin, L.J. Marnett, and A.R. Brash The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase Proc. Natl. Acad. Sci. U. S. A. 100 2003 9162 9167
37. P. Krieg, S. Rosenberger, and S. de Juanes Aloxe3 knockout mice reveal a function of epidermal lipoxygenase-3 as hepoxilin synthase and its pivotal role in barrier formation J. Invest. Dermatol. 133 2013 172 180
38. C. Schneider, D. Keeney, W. Boeglin, and A. Brash Detection and cellular localization of 12R-lipoxygenase in human tonsils Arch. Biochem. Biophys. 38 2001 268 274
39. Z. Yu, C. Schneider, W. Boeglin, and A. Brash Human and mouse eLOX3 have distinct substrate specificities: implications for their linkage with lipoxygenases in skin Arch. Biochem. Biophys. 455 2006 188 196
40. S. Nigam, M.-P. Zafiriou, and R. Deva Hepoxilin A3 (HXA3) synthase deficiency is causative of a novel ichthyosis form FEBS Lett. 582 2008 279 285
41. P. Krieg, A. Kinzig, and M. Ress-Loschke 12-Lipoxygenase isoenzymes in mouse skin tumor development Mol. Carcinog. 14 1995 118 129
42. R. Antón, M. Camacho, L. Puig, and L. Vila Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions J. Invest. Dermatol. 118 2002 139 146
43. R. Anton, L. Puig, T. Esgleyes, J.M. de Moragas, and L. Vila Occurrence of hepoxilins and trioxilins in psoriatic lesions J. Invest. Dermatol. 110 1998 303 310
44. M. Siebert, P. Krieg, W.D. Lehmann, F. Marks, and G. Furstenberger Enzymic characterization of epidermis-derived 12-lipoxygenase isoenzymes Biochem. J. 355 2001 97 104
45. R. Bryant, T. Simon, and J. Bailey Role of glutathione peroxidase and hexose monophosphate shunt in the platelet 12-lipoxygenase pathway J. Biol. Chem. 257 1982 14937 14943
46. R.W. Bryant, and J.M. Bailey Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium deficient rats Biochem. Biophys. Res. Commun. 92 1 1980 268 276
47. R. Jones, P. Kerry, N. Poyser, I. Walker, and N. Wilson The identification of trihydroxyeicosatrienoic acids as products from the incubation of arachidonic acid with washed blood platelets Prostaglandins 16 1978 583 590
48. K. Honn, D. Tang, and X. Gao 12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis Cancer Metastasis Rev. 13 1994 365 396
49. D. Bleich, S. Chen, B. Zipser, D. Sun, C.D. Funk, and J.L. Nadler Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice J. Clin. Invest. 103 1999 1431 1436
50. K. Nozawa, M.L. Tuck, M. Golub, P. Eggena, J.L. Nadler, and N. Stern Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats Am. J. Physiol. Heart Circ. Physiol. 259 6 1990 H1774 H1780
51. O. Laneuville, R. Couture, and C.R. Pace-Asciak Hepoxilins sensitize blood vessels to noradrenaline - stereospecificity of action Br. J. Pharmacol. 105 1992 297 304
52. O. Laneuville, R. Couture, and C.R. Pace-Asciak Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins Br. J. Pharmacol. 107 1992 808 812
53. C. Pace-Asciak Hepoxilins in cancer and inflammation - use of hepoxilin antagonists Cancer Metastasis Rev. 30 3 2011 493 506
54. K. Sakai, V. Fafeur, B. Vulliez-Le-Normand, and F. Dray 12-Hydroperoxyeicosatetraenoic acid (12-HPETE) and 15-HPETE stimulate melatonin synthesis in rat pineal Prostaglandins 35 1988 969 976
55. N. Qiao, D. Reynaud, P. Demin, P.V. Halushka, and C.R. Pace-Asciak The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPα isoform in transfected COS-7 cells J. Pharmacol. Exp. Ther. 307 2003 1142 1147
56. C.R. Pace-Asciak, D. Reynaud, P. Demin, R. Aslam, and A. Sun A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition J. Pharmacol. Exp. Ther. 301 2002 618 624
57. S. Dho, S. Grinstein, E.J. Corey, W.G. Su, and C.R. Pace-Asciak Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils Biochem. J. 266 1990 63 68
58. D. Reynaud, P. Demin, and C.R. Pace-Asciak Coupling of Hepoxilin A3-specific Binding with Calcium-mobilizing Actions in Human Neutrophils K. Schrör, C.R. Pace-Asciak, Mediators in the Cardiovascular System - Regional Ischemia Agents and Actions Supplements vol. 45 1995 Birkhauser Verlag Basel 291 296
59. C. Lowe, S. O'Rahiily, and R. Rochford Adipogenesis at a glance J. Cell Sci. 124 2011 2681 2686
60. P. Hallenborg, C. Jørgensen, and R. Petersen Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor-γ activity Mol. Cell. Biol. 30 2010 4077 4091
61. B. Forman, P. Tontonoz, J. Chen, R.P. Brun, B. Spiegelman, and R. Evans 15-Deoxy-delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARgamma Cell 83 5 1995 803 812
62. S. Kliewer, J. Lenhard, T. Willson, I. Patel, D. Morris, and J. Lehmann A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83 1995 813 819
63. L. Madsen, R. Petersen, and M. Sørensen Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process Biochem. J. 375 2003 539 549
64. K. Ge, Y.-W. Cho, and H. Guo Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor γ-stimulated adipogenesis and target gene expression Mol. Cell. Biol. 28 2008 1081 1091
65. K. Ge, M. Guerah, and C. Yuan Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis Nature 417 6888 May 30 2002 56 (2002;417(6886):563-567)
66. K. Uchida, and T. Shibata 15-Deoxy-Δ12,14-prostaglandin J2: an electrophilic trigger of cellular responses Chem. Res. Toxicol. 21 2008 138 144
67. A. Soares, O. Nosjean, and D. Cozzone Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARγ Biochem. Biophys. Res. Commun. 337 2005 521 525
68. M. Koller, and W. Konig 12-Hydroxyeicosatetraenoic acid (12-HETE) induces heat shock proteins in human leukocytes Biochem. Biophys. Res. Commun. 175 3 1991 804 809
69. M. Köller, and W. König Arachidonic acid metabolism in heat-shock treated human leucocytes Immunology 70 4 Aug 1990 458 464 (1990;70:458-464)
70. D. Reynaud, and C.R. Pace-Asciak 12-HETE and 12-HPETE potently stimulate intracellular release of calcium in intact human neutrophils Prostaglandins Leukot. Essent. Fatty Acids 56 1997 9 12
71. Z. Lin, O. Laneuville, and C.R. Pace-Asciak Hepoxilin A3 induces heat shock protein (HSP72) expression in human neutrophils Biochem. Biophys. Res. Commun. 179 1 1991 52 56
72. H. Beere, B. Wolf, and K. Cain Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome Nat. Cell Biol. 2 2000 469 475
73. X. Li, N. Qiao, D. Reynaud, M. Abdelhaleem, and C.R. Pace-Asciak The hepoxilin analog, PBT-3, inhibits growth of K-562 CML solid tumours in vivo in nude mice In Vivo 19 2005 185 190
74. N. Qiao, J. Lam, D. Reynaud, M. Abdelhaleem, and C.R. Pace-Asciak The hepoxilin analog PBT-3 induces apoptosis in BCR-ABL-positive K562 leukemia cells Anticancer Res 23 2003 3617 3622
75. D. Reynaud, P. Demin, and C.R. Pace-Asciak Hepoxilin A3-specific binding in human neutrophils Biochem. J. 313 1996 537 541
76. B.P. Hurley, D. Siccardi, R.J.Mrsny., and B.A. McCormick Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A3 J. Immunol. 1 2004 5712 5720
77. B.A. McCormick Bacterial-induced hepoxilin A3 secretion as a pro-inflammatory mediator FEBS J. 274 2007 3513 3518
78. R.J. Mrsny, A.T. Gewirtz, and D. Siccardi Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia Proc. Natl. Acad. Sci. U. S. A. 101 2004 7421 7426
79. D. Tamang, W. Pirzai, and G. Priebe Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers J. Immunol. 189 2012 4960 4969
80. V.A. Blaho, M.W. Buczynski, C.R. Brown, and E.A. Dennis Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis J. Biol. Chem. 284 2009 21599 21612
81. M.W. Buczynski, C.I. Svensson, and D.S. Dumlao Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord J. Neurochem. 114 2010 961 993
82. A.M. Gregus, D.S. Dumlao, B.L. Fitzsimmons, X.-Y. Hua, E.A. Dennis, and T.L. Yaksh Spinal 12-Lipoxygenases Contribute to Carrageenan-mediated Inflammatory Hyperalgesia 2010 IASP
83. D. Reynaud, P.M. Demin, and C.R. Pace-Asciak Hepoxilin binding in human neutrophils Biochem. Biophys. Res. Commun. 207 1995 191 194
84. D. Reynaud, P.M. Demin, and C.R. Pace-Asciak Hepoxilin-specific Binding in Rat Brain Presented at the 27th Annual Meeting of the American Society for Neurochemistry, Philadelphia, PA, March 2-6, 1996, Abstract # S44A 1996
85. M. Sutherland, T. Schewe, and S. Nigam Biological actions of the free acid of hepoxilin A3 on human neutrophils Biochem. Pharmacol. 59 2000 435 440
86. R.P. Jankov, X. Luo, and P. Demin Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse J. Pharmacol. Exp. Ther. 301 2002 435 440
87. A. Hofer Another dimension to calcium signaling: a look at extracellular calcium J. Cell Sci. 118 2005 855 862
88. A. Dembinska-Kiec, W. Rucker, and P.S. Schonohofer Atherosclerosis decreased prostacyclin formation in rabbit lungs and kidneys Prostaglandins 17 1979 831 838
89. M. Rebecchi, and S. Pentyala Structure, function, and control of phosphoinositide-specific phospholipase C Physiol. Rev. 80 2000 1233 1291
90. S. Nigam, S. Nodes, G. Cichon, E.J. Corey, and C.R. Pace-Asciak Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils Biochem. Biophys. Res. Commun. 171 1990 944 948
91. A. Guse Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR) FEBS J. 272 2005 4590 4597
92. L. Mills, D. Reynaud, and C.R. Pace-Asciak Hepoxilin-evoked intracellular reorganization of calcium in human neutrophils: a confocal microscopy study Exp. Cell Res. 230 1997 337 341
93. D. Reynaud, P.M. Demin, M. Sutherland, S. Nigam, and C.R. Pace-Asciak Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3 FEBS Lett. 446 1999 236 238
94. O. Laneuville, D. Reynaud, S. Grinstein, S. Nigam, and C.R. Pace-Asciak Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4 Biochem. J. 295 1993 393 397
95. C.R. Pace-Asciak, D. Reynaud, P.M. Demin, and S. Nigam The hepoxilins - a review Adv. Exp. Med. Biol. 447 1999 ((Nigam, S., and Pace-Asciak, C.R., Eds.), Kluwer Academic/Plenum, New York.:123-132)
96. L.O. Derewlany, C.R. Pace-Asciak, and I.C. Radde Hepoxilin A, hydroxyepoxide metabolite of arachidonic acid stimulates transport of calcium-45 across the guinea-pig visceral yolk sac Can. J. Physiol. Pharmacol. 62 1984 1466 1469
97. W. Campbell, N. Spitzbarth, K. Gauthier, and S. Pfister 11,12,15-Trihydroxyeicosatrienoic acid mediates ACh-induced relaxations in rabbit aorta Am. J. Physiol. Heart Circ. Physiol. 285 2004 H2648 H2656
98. K. Gauthier, Y. Chawengsub, and D. Goldman 11(R),12(S),15(S)-Trihydroxyeicosa-5(Z),8(Z),13(E)-trienoic acid: an endothelium-derived 15-lipoxygenase metabolite that relaxes rabbit aorta Am. J. Physiol. Heart Circ. Physiol. 294 2007 467 472
99. S. Pfister, N. Spitzbarth, K. Kasem Nithipatikom, J. Falck, and W. Campbell Metabolism of 12-hydroperoxyeicosatetraenoic acid to vasodilatory trioxilin C3 by rabbit aorta Biochim. Biophys. Acta Gen. Subj. 1622 2003 6 13
100. P. Crunkhorn, and A. Willis Cutaneous reactions to intradermal prostaglandins Br. J. Pharmacol. 41 1971 49 56
101. O. Laneuville, E.J. Corey, R. Couture, and C.R. Pace-Asciak Hepoxilin A3 increases vascular permeability in the rat skin Eicosanoids 4 1991 95 97
102. O. Laneuville, E.J. Corey, and C.R. Pace-Asciak Hepoxilin A3: A Potential Mediator of Inflammation in the Skin With R-stereospecificity Martyn Bailey, Prostaglandins, Leukotrienes, Lipoxins & PAF, XIth, Washington International Spring Symposium 1991 Plenum Press New York 335 338 (1991:Abstract # 155)
103. B. Hurley, W. Pirzai, K. Mumy, K. Gronert, and B. McCormick Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2 2011 L286 L294
104. P.M. Demin, D.M. Kochev, H. Perrier, C.R. Pace-Asciak, and K.K. Pivnitsky Synthesis of a photoaffinic hepoxilin analog Mendeleev Commun. 7 1997 90 91
105. S. Straub, and G. Sharp Glucose-stimulated signaling pathways in biphasic insulin secretion Diabetes Metab. Res. Rev. 18 2002 451 463
106. C.R. Pace-Asciak, P.M. Demin, M. Estrada, and G.-Y. Liu Hepoxilins raise circulating insulin levels in vivo FEBS Lett. 461 1999 165 168
107. A. Dobrian, D. Lieb, B. Cole, D. Taylor-Fishwick, S. Chakrabarti, and J. Nadler Functional and pathological roles of the 12- and 15-lipoxygenases Prog. Lipid Res. 50 1 Jan 2011 115 131 (2011;50:115-131)
108. P.L. Carlen, N. Gurevich, L. Zhang, P.H. Wu, D. Reynaud, and C.R. Pace-Asciak Formation and electrophysiological actions of the arachidonic acid metabolites, hepoxilins, at nanomolar concentrations in rat hippocampal slices Neuroscience 58 1994 493 502
109. R.K. Amer, C.R. Pace-Asciak, and L.R. Mills A lipoxygenase product, hepoxilin A3, enhances nerve growth factor-dependent neurite regeneration post-axotomy in rat superior cervical ganglion neurons in vitro Neuroscience 116 2003 935 946
110. P.L. Carlen, N. Gurevich, P.H. Wu, W.-G. Su, E.J. Corey, and C.R. Pace-Asciak Actions of arachidonic acid and hepoxilin A3 on mammalian CA1 neurons Brain Res. 497 1989 171 176
111. C. Pace-Asciak, L. Wong, and E. Corey Hepoxilin A3 blocks the release of norepinephrine from rat hippocampal slices Biochem. Biophys. Res. Commun. 173 1990 949 953
112. B. Samuelsson Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation Science 220 1983 568 575
113. B. Samuelsson Leukotrienes: a new class of mediators of immediate hypersensitivity reactions and inflammation Adv. Prostaglandin Thromboxane Leukot. Res. 11 1983 1 13
114. B. Samuelsson The Leukotrienes: An Introduction B. Samuelsson, R. Paoletti, Leukotrienes and Other Lipoxygenase Products vol. 9 1982 Raven Press New York 1 17
115. B. Samuelsson, P. Borgeat, S. Hammarstrom, and R.C. Murphy Leukotrienes: a new group of biologically active compounds Adv. Prostaglandin Thromboxane Res. 6 1980 1 6
116. B. Samuelsson, P. Borgeat, S. Hammarstrom, and R.C. Murphy Introduction of a nomenclature: leukotrienes Prostaglandins 17 6 1979 785 787
117. A. Sardini, J. Ameya, K.-H. Weylandt, M. Nobles, M. Valverded, and C. Higgins Cell volume regulation and swelling-activated chloride channel Biochim. Biophys. Acta 1618 2003 153 162
118. A. Livne, S. Grinstein, and A. Rothstein Volume-regulating behaviour of human platelets J. Cell. Physiol. 131 1987 354 363
119. A. Margalit, and A.A. Livne Lipoxygenase product controls the regulatory volume decrease of human platelets Platelets 2 1991 207 214
120. D. Piomelli, E. Shapiro, R. Zipkin, J. Schwartz, and S. Feinmark Formation and action of 8-hydroxy-11,12-epoxy-5,9,14-eicosatrienoic acid in aplysia: a possible second messenger in neurons Proc. Natl. Acad. Sci. U. S. A. 86 1989 1721 1725
121. F. Belardetti, W.B. Campbell, J.R. Falck, G. Demontis, and M. Rosolowsky Products of heme-catalyzed transformation of the arachidonate derivative 12-HPETE open S-type K+ channels in Aplysia Neuron 3 1989 497 505
122. D. Piomelli, and P. Greengard Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling TIPS 11 1990 367 373
123. M. Michael Pazos, D. Siccardi, and K.L. Mumy Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3 J. Immunol. 181 2008 8044 8052
124. G. Larsen, and P. Henson Mediators of inflammation Annu. Rev. Immunol. 1 1983 335 357 (1: 33)
125. P. Davies, P. Bailey, M. Goldenberg, and A. Ford-Hutchinson The role of arachidonic acid oxygenation products in pain and inflammation Annu. Rev. Immunol. 2 1984 335 357 (1984;2:335-357)
126. M. Hamberg, and C. Johnsson Increased synthesis of prostaglandins in the guinea pig following scalding injury Acta Physiol. Scand. 87 1973 240 245
127. S. Ferreira, S. Moncada, and J. Vane Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs Br. J. Pharmacol. 49 1973 86 97
128. A. Rackham, and A. Ford-Hutchinson Inflammation and pain sensitivity: effects of leukotrienes D4, B4 and prostaglandin E1 in the rat paw Prostaglandins 25 1983 193 203
129. J. Levine, D. Lam, Y. Taiwo, P. Donatoni, and E. Goetzl Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid Proc. Natl. Acad. Sci. U. S. A. 83 1986 5331 5334
130. J. Levine, W. Lau, G. Kwiat, and E. Goetzl Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes Science 225 1984 743 745
131. S. Hwang, H. Cho, and J. Kwak Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances Proc. Natl. Acad. Sci. U. S. A. 97 2000 6155 6160
132. A. Gregus, S. Doolen, and D. Dumlao Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors Proc. Natl. Acad. Sci. U. S. A. 109 2012 6721 6726
133. D. Stocum Amphibian regeneration and stem cells Curr. Top. Microbiol. Immunol. 280 2004 1 70
134. M. Behne, Y. Uchida, T. Seki, P. de Montellano, P. Elias, and W. Holleran Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function J. Invest. Dermatol. 14 2000 185 192
135. M.M. Wang, P.M. Demin, and C.R. Pace-Asciak Epimer-specific actions of hepoxilins A3 and B3 on PAF- and bradykinin-evoked vascular permeability in the rat skin in vivo Adv. Exp. Med. Biol. 416 1996 239 241
136. V. O'Donnell, and R. Murphy New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions Blood 120 2012 1985 1992
137. D. Reynaud, O. Rounova, P.M. Demin, K.K. Pivnitsky, and C.R. Pace-Asciak Hepoxilin A3 is oxidized by human neutrophils into its omega-hydroxy metabolite by an activity independent of LTB4 omega-hydroxylase Biochim. Biophys. Acta Lipids Lipid Metab. 1348 1997 287 298
138. C.R. Pace-Asciak, X. Li, N. Qiao, D. Reynaud, P. Demin, and M. Abdelhaleem Hepoxilin analogs, potential new therapeutics in disease Curr. Pharm. Des. 12 2006 963 969
139. C. Pace-Asciak Development of Novel Anti-inflammatory and Antidiabetic Drugs Essential Fatty Acids and Eicosanoids Fifth International Congress 2003 247 250
140. J. Kelley, R. Newman, and J. Evans Bleomycin-induced pulmonary fibrosis in the rat J. Lab. Clin. Med. 96 1980 954 964
141. J. Cooper, R. Zitnik, and R. Matthay Mechanisms of drug-induced pulmonary disease Annu. Rev. Med. 39 1988 395 404
142. S. Giri, and M. Hollinger Effect of nordihydroguaiaretic acid and ibuprofen on bleomycin and hyperoxia-induced changes in lung superoxide dismutase, prostaglandins and lethality Arch. Toxicol. 70 1996 271 276
143. G. Gurujeyalakshmi, and S. Giri Molecular mechanisms of anti-fibrotic effect of interferon-gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression Exp. Lung Res. 21 1995 791 808
144. S. Kubala, S. Patil, W. Shreffler, and B. Hurley Pathogen induced chemo-attractant hepoxilin A3 drives neutrophils, but not eosinophils across epithelial barriers Prostaglandins Other Lipid Mediat. 108 2014 1 8
145. X. Li, N. Qiao, D. Reynaud, M. Abdelhaleem, and C.R. Pace-Asciak PBT-3, a hepoxilin stable analog, causes long term inhibition of growth of K562 solid tumours in vivo Biochem. Biophys. Res. Commun. 338 2005 158 160
146. X. Gao, and K. Honn Biological properties of 12(S)-HETE in cancer metastasis. [Review] Adv. Prostaglandin Thromboxane Leukot. Res. 23 1995 439 444
147. K. Scott, M. Sajinovoc, and J. Hein Emerging roles for phospholipase A2 in cancer Biochimie 92 2010 601 610
148. S. Yamashita, J. Yamashita, and M. Ogawa Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency Br. J. Cancer 69 1994 1166 1170
149. M. Hatala, J. Rayburn, and D. Rose Characterization of phospholipase A2 activity in MDA-MB-435 human breast cancer cells Cancer Lett. 72 1993 31 37
150. Z. Dong, Y. Liu, and K. Scott Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer Carcinogenesis 31 2010 948 955
151. C.R. Pace-Asciak, D. Reynaud, and P.M. Demin Hepoxilins: a review on their enzymatic formation, metabolism and chemical synthesis Lipids 30 1995 107 114